Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q1 2026 · 10-Q
Revenue$627.78M$627.78M−6.8% vs Q1 2025 Net Income-$6.47M-$6.47MN/M vs Q1 2025 EPS Diluted-$0.08-$0.08N/M vs Q1 2025 Operating Income$17,125,000−13.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Free Cash Flowderived-$91,723,000N/M Margins · derivedOperating margin2.7%−0.2 pt vs Q1 2025
Net margin-1.0%+2.7 pt vs Q1 2025
ended Mar 31, 2026 · filed May 11, 2026 · 41 d after period end